Find a TenderAwarded without competition
Published 14 Jun 2023, 10:52 BST

Official UK procurement notice

High resolution, in situ platform to combine single-cell and spatial genomics analyses.

Official notice

Authority: UNIVERSITY OF MANCHESTER (Education)

GoodsAward procedure without prior publication of a call for competition
Awarded value£428,000published contract · exc. VAT
Awarded 8 Jun 2023no call for competition
Awarded to Vizgen Inc.

What is being bought

Published requirement description

The high resolution, in situ platform to combine single-cell and spatial genomics analyses, is required by the Genomic Technologies Core Facility (GTCF). Enabling multiplexed, error-robust, single-cell in situ transcriptomic imaging from whole tissue to subcellular resolution.

CPV: Medical equipments · Medical equipments, pharmaceuticals and personal care products

The lotProcurement structure

single lot · no lot value published
Lot #1Research - Genomic Technologies Core Facility (GTCF)
Delivery: North West · The University of Manchester

Procedure terms & legal framework

From the official record
Procedure method
Award procedure without prior publication of a call for competition
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded without competition
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Direct award (no call for competition)
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
14 Jun 2023, 10:52 BST
Last source update
14 Jun 2023, 10:52 BST
Authority reference
2023/2060/HRSP/AHKC/AS/KC/AH/JD
FTS notice number
2023/S 000-016817
Classification (CPV)
Medical equipmentsMedical equipments, pharmaceuticals and personal care products
Delivery area
North West (UKD3)
Official registry OCID
ocds-h6vhtk-03d602 Find a Tender
Why no open competition
The procurement falls outside the scope of application of the directive
Published justification

The High resolution in situ platform to combine single-cell and spatial genomics analyses, is required by the Genomic Technologies Core Facility

The High resolution in situ platform to combine single-cell and spatial genomics analyses is provided by Vizgen Inc., who are the sole provider of the MERSCOPE Platform. MERSCOPE is the

MERFISH technology platform solution developed by the supplier. The MERSCOPE Platform is powered by MERFISH (Multiplexed Error Robust in situ Hybridization) technology, which is exclusively licensed to Vizgen by Harvard University for commercialisation.

This solution enables multiplexed, error-robust, single-cell in situ transcriptomic imaging from whole tissue to subcellular resolution.

This product and it's use is covered by U.S. patents

Review and risk notes
Review procedure

The Authority will incorporate a minimum 10 calendar day standstill period at the point of publication of this VEAT notice.

Note: A purchase order will not be raised until after the ten day notice of intention to contract.

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1
Awarded value £428,0001 contract exc. VAT
Contracts signed 1latest 8 Jun 2023
Awarded toValueDateStatus
Vizgen Inc.£428,000 †—Awarded

Contracts

  • High resolution, in situ platform to combine single-cell and spatial genomics analyses · Vizgen Inc.

    Signed
    8 Jun 2023
    Value
    £428,000
    Status
    active

Contracting authority & participating public bodies

UNIVERSITY OF MANCHESTER

Contracting authorityEducationBody governed by public lawEducation GB-COH: RC000797 MANCHESTER, North West, M13 9PLContact name, email

Dispute resolution & review bodies

  • The High Court of Justice of EnglandReview body London

Bidders & participating suppliers

1 commercial party on the notice

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.